What question did this study set out to answer?

This study evaluates the prognostic significance of RAS-MAPK pathway mutations in newly diagnosed acute myeloid leukemia patients.

December 8, 2025BloodOpen Access

Clinical significance of RAS-MAPK pathway mutations in Acute Myeloid Leukemia: Insights from a retrospective cohort

View Full Paper

Ask AI

Bookmark

Authors

Retrospective cohort finds KRAS mutations significantly increase mortality in acute myeloid leukemia, highlighting the role of molecular profiling.

This study evaluates the prognostic significance of RAS-MAPK pathway mutations in newly diagnosed acute myeloid leukemia patients.
Retrospective cohort study of adult patients with newly diagnosed AML
Data collection included demographics, treatment regimens, and molecular profiles
Next-generation sequencing (NGS) determined mutations in NRAS, KRAS, BRAF, NF1, and PTPN11
Primary endpoints included complete composite remission, overall survival, and event-free survival
KRAS mutations associated with a twofold increase in mortality
Mutations in RAS-MAPK pathway exhibited distinct clinicopathological differences
BRAF mutations were rare but linked to poor survival, though statistically insignificant

Albliwi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Retrospective cohort finds KRAS mutations significantly increase mortality in acute myeloid leukemia, highlighting the role of molecular profiling.

This study evaluates the prognostic significance of RAS-MAPK pathway mutations in newly diagnosed acute myeloid leukemia patients.
Retrospective cohort study of adult patients with newly diagnosed AML
Data collection included demographics, treatment regimens, and molecular profiles
Next-generation sequencing (NGS) determined mutations in NRAS, KRAS, BRAF, NF1, and PTPN11
Primary endpoints included complete composite remission, overall survival, and event-free survival
KRAS mutations associated with a twofold increase in mortality
Mutations in RAS-MAPK pathway exhibited distinct clinicopathological differences
BRAF mutations were rare but linked to poor survival, though statistically insignificant

Albliwi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark